Bioavailability of a co-formulated combination of amodiaquine and artesunate under fed and fasted conditions: A randomised, open-label crossover study

Arzneimittel-Forschung/Drug Research

Volumn 59, Issue 7, 2009, Pages 370-376

  Fitoussi, Serge ^a   Thang, Carole ^a   Lesauvage, Eric ^a   Barré, Jérôme ^b   Charron, Brigitte ^c   Filali Ansary, Aziz ^c   Lameyre, Valérie ^c  

^a MEDISCIS   (France)

^b CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^c SANOFI   (France)

Author keywords

Amodiaquine; Artesunate; CAS 182824 33 5; CAS 6398 98 7; Coarsucam ; Fixed dose anti malarial combination, food effect, pharmacokinetics

Indexed keywords

AMODIAQUINE; AMODIAQUINE PLUS ARTESUNATE; ARTESUNATE; COARSUCAM; DEETHYLAMODIAQUINE; DIHYDROARTEMISININ; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; FOOD; FOOD DRUG INTERACTION; HUMAN; HUMAN EXPERIMENT; LIPID DIET; MALE; NORMAL HUMAN; SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT;

EID: 69249091700     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296410     Document Type: Article

References (13)

1. Olumese P et al. WHO Guidelines for the treatment of Malaria. Geneva: WHO Library Cataloguing-in-Publication Data; 2006.
2. Menard D, Andrianina NN, Ramiandrasoa Z, Randriamanantena A, Rasoarilalao N, Jahevitra M, et al . Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar. Malar J. 2007;6:65. (Pubitemid 46868459)
3. Nosten F, White NJ. Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg. 2007; 77:181-192
4. Adjuik M, Agnamey P, Babiker A, Borrmann S, Brasseur P, Cisse M, et al . Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet. 2002;359:1365-1372 (Pubitemid 34442375)
5. White NJ. Delaying antimalarial drug resistance with combination chemotherapy. Parasitologia. 1999;41:301-308
6. Luo XD, Shen CC. The chemistry, pharmacology, and clinical applications of qinghaosu (artemisinin) and its derivatives. Med Res Rev. 1987;7:29-52.
7. Krishna S, White NJ. Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications. Clin Pharmacokinet . 1996;30:263-299
8. Sirima SB, Gansane A. Artesunate-amodiaquine for the treatment of uncomplicated malaria. Expert Opin Investig Drugs . 2007;16:1079-1085
9. Dien TK, de Vries PJ, Khanh NX, Koopmans R, Binh LN, Duc DD, et al . Effect of food intake on pharmacokinetics of oral artemisinin in healthy Vietnamese subjects. Antimicrob Agents Chemother. 1997;41:1069-1072 (Pubitemid 27194187)
10. Davis TM, Karunajeewa HA, Ilett KF. Artemisinin-based combination therapies for uncomplicated malaria. Med J Aust. 2005;182:181-185 (Pubitemid 40298186)
11. Ezzet F, van Vugt M, Nosten F, Looareesuwan S, White NJ. Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria. Antimicrob Agents Chemother . 2000;44:697-704. (Pubitemid 30117964)
12. Ashley EA, Stepniewska K, Lindegardh N, Annerberg A, Kham A, Brockman A, et al . How much fat is necessary to optimize lumefantrine oral bioavailability? Trop Med Int Health. 2007;12:195-200.
13. Hietala SF, Bhattarai A, Msellem M, Roshammar D, Ali AS, Stromberg J, et al. Population pharmacokinetics of amodiaquine and desethylamodiaquine in pediatric patients with uncomplicated falciparum malaria. J Pharmacokinet Pharmacodyn . 2007;34:669-686 (Pubitemid 47477038)